UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 16, 2004
Commission File No. 0-11178
-------
UTAH MEDICAL PRODUCTS, INC.
---------------------------
(Exact name of Registrant as specified in its charter)
UTAH 87-0342734
------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
7043 South 300 West
Midvale, Utah 84047
-------------------
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
--------------
--------------------------------------------------------------------------------
ITEM 5. OTHER EVENTS
--------------------------------------------------------------------------------
On August 16, 2004, Utah Medical Products, Inc. issued a press release in which
its independent directors comment on FDA allegations. A copy of the press
release is attached hereto as Exhibit 99.1
--------------------------------------------------------------------------------
SIGNATURES
--------------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
---------------------------
REGISTRANT
Date: 8/17/2004 By: /s/ Kevin L. Cornwell
--------------------- --------------------------
Kevin L. Cornwell
CEO
--------------------------------------------------------------------------------
EXHIBIT INDEX
Index
Number Description
------ -----------
99.1 Press release issued August 16, 2004: UTMD's Board of Directors
Comments of FDA Allegations.